A comparative clinical trial to assess the effect of kusthkalanal cream ang kusthakalanal tail in shvitra with special refrence to bhrajak pitta
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
Dissertation titled A Comparative Clinical Trial to Assess the Efficacy of Kusthakalanal Cream and Kusthakalanal Tail in Shvitra with Special Reference to Bhrajaka Pitta is being conducted in the Department of Kriya Sharir at the National Institute of Ayurveda, Jaipur.
Shvitra, correlated with vitiligo in modern dermatology, is a depigmentary skin disorder described under Kushtha in Ayurveda and associated with vitiation of Bhrajaka Pitta. Vitiligo has a prevalence ranging from 0.25% to 4% in India, with higher rates reported in Rajasthan and Gujarat. Despite multiple treatment approaches, there is a need for effective, patient-friendly topical therapies.
This study aims to compare the clinical efficacy of Kusthakalanal Cream (a newly formulated cream using Kusthakalanal Tail as the active ingredient) and Kusthakalanal Tail (classical oil formulation mentioned in Gadnigraha) in the management of Shvitra.
It is a randomized, open-label, comparative interventional Phase II clinical trial involving 40 patients divided into two groups: Group A (20 patients): Kusthakalanal Cream (topical application twice daily)Group B (20 patients): Kusthakalanal Tail (topical application twice daily)
The duration of treatment is 90 days, with follow-up assessment. The primary outcome measure is improvement in the Vitiligo Area Severity Index (VASI) score. Secondary assessment includes classical Ayurvedic signs and evaluation of Bhrajaka Pitta involvement.
The study intends to scientifically evaluate whether the cream formulation offers better absorption, compliance, and therapeutic effectiveness compared to the traditional oil preparation. The findings may help bridge traditional Ayurvedic formulations with modern dermatological applications and provide improved patient-centered management strategies for Shvitra.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •Clinically diagnosed subjects of Shvitra of both of sex in the age group 18-60 years.
- •Subjects who are in between 10%-75% range of VASI score will be selected.
排除标准
- •Shvitra is associated with other diseases like chronic systemic diseases, Uncontrolled Hypertension, Uncontrolled Diabetes Mellitus, Heart diseases, Kidney diseases, Blood disorders, sexually transmitted diseases, or any organ failure.
- •Pregnant and breastfeeding mothers.
- •Taking any other medication for the same illness.
研究者
Dr Ajeet Kumar Marothia
national institute of ayurveda
